In the mammary tumors developed in mice, CXCL5 (a CXCR2 ligand) and CCL5 (a ligand for CCR1/3/5) can promote infiltration of MDSCs and Treg cells respectively [42,43], although their roles at metastatic sites remain to be identified. Here, CXCR2 is linked to breast cancer.